Stephan Rössner

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

Luc F. Van Gaal, Aila Rissanen, André Scheen et al. · The Lancet · 2005 · 1.5K citations · Full text

Obesity, Metabolic Syndrome, Cannabis Use +10

Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study

Arne Astrup, Stephan Rössner, Luc Van Gaal et al. · The Lancet · 2009 · 1.1K citations

Obesity, Nutrition, Metabolic Syndrome +6

Effect of sibutramine on weight maintenance after weight loss: a randomised trial

W. P. T. James, Arne Astrup, Nick Finer et al. · The Lancet · 2000 · 817 citations

Obesity, Nutrition, Weight Loss +8

Weight Loss, Weight Maintenance, and Improved Cardiovascular Risk Factors after 2 Years Treatment with Orlistat for Obesity

Stephan Rössner, Lars Sjöström, R. Noack et al. · Obesity Research · 2000 · 479 citations · Full text

Long‐Term Weight Development in Women: A 15‐Year Follow‐up of the Effects of Pregnancy

Yvonne Linné, Louise Dye, Britta Barkeling et al. · Obesity Research · 2004 · 361 citations